BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang W, Cui J, Ma H, Lu W, Huang J. Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine. Front Oncol 2021;11:684961. [PMID: 34123854 DOI: 10.3389/fonc.2021.684961] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Majumder S, Manna SK. Rewiring of Drug Metabolism and Its Cross‐talk with Metabolic Reprogramming in Cancer. Drug Metabolism Handbook 2022. [DOI: 10.1002/9781119851042.ch27] [Reference Citation Analysis]
2 Kim DH, Kim JS, Mok CS, Chang EH, Choi J, Lim J, Kim CH, Park AR, Bae YJ, Koo BS, Lee HC. dTMP imbalance through thymidylate 5'-phosphohydrolase activity induces apoptosis in triple-negative breast cancers. Sci Rep 2022;12:20027. [PMID: 36414668 DOI: 10.1038/s41598-022-24706-4] [Reference Citation Analysis]
3 Wu F, Yan Z, Ran Y, Wang M, Yang S, Huang M, Zhou S, Zhang P, Jiang B, Liang P. Metabolic changes of endothelial cells in post-burn patients using UHPLC-MS/MS.. [DOI: 10.21203/rs.3.rs-2237210/v1] [Reference Citation Analysis]
4 Schild T, Keshari KR. Revealing de novo pyrimidine synthesis as a key vulnerability in brain tumors. Cancer Cell 2022. [DOI: 10.1016/j.ccell.2022.10.023] [Reference Citation Analysis]
5 Peter TK, Withanage MHH, Comnick CL, Pendleton C, Dabdoub S, Ganesan S, Drake D, Banas J, Xie XJ, Zeng E. Systematic review and meta-analysis of oral squamous cell carcinoma associated oral microbiome. Front Microbiol 2022;13:968304. [DOI: 10.3389/fmicb.2022.968304] [Reference Citation Analysis]
6 Lackner M, Neef SK, Winter S, Beer-hammer S, Nürnberg B, Schwab M, Hofmann U, Haag M. Untargeted stable isotope-resolved metabolomics to assess the effect of PI3Kβ inhibition on metabolic pathway activities in a PTEN null breast cancer cell line. Front Mol Biosci 2022;9:1004602. [DOI: 10.3389/fmolb.2022.1004602] [Reference Citation Analysis]
7 Hamidi M, Eriz A, Mitxelena J, Fernandez-Ares L, Aurrekoetxea I, Aspichueta P, Iglesias-Ara A, Zubiaga AM. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity. Cancers (Basel) 2022;14:4952. [PMID: 36230876 DOI: 10.3390/cancers14194952] [Reference Citation Analysis]
8 Liu F, Gai X, Wu Y, Zhang B, Wu X, Cheng R, Tang B, Shang K, Zhao N, Deng W, Chen J, Zhang Z, Gu S, Zheng L, Zhang H. Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer. Proc Natl Acad Sci U S A 2022;119:e2202157119. [PMID: 36122209 DOI: 10.1073/pnas.2202157119] [Reference Citation Analysis]
9 Heo H, Kim JH, Lim HJ, Kim JH, Kim M, Koh J, Im JY, Kim BK, Won M, Park JH, Shin YJ, Yun MR, Cho BC, Kim YS, Kim SY, Kim M. DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy. Exp Mol Med 2022. [PMID: 35999456 DOI: 10.1038/s12276-022-00836-7] [Reference Citation Analysis]
10 Sepúlveda CS, García CC, Damonte EB. Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy. Microorganisms 2022;10:1631. [PMID: 36014049 DOI: 10.3390/microorganisms10081631] [Reference Citation Analysis]
11 Feng M, Hou T, Zhou M, Cen Q, Yi T, Bai J, Zeng Y, Liu Q, Zhang C, Zhang Y. Gut microbiota may be involved in Alzheimer’s disease pathology by dysregulating pyrimidine metabolism in APP/PS1 mice. Front Aging Neurosci 2022;14:967747. [DOI: 10.3389/fnagi.2022.967747] [Reference Citation Analysis]
12 Jayarathna DK, Rentería ME, Batra J, Gandhi NS. A supervised machine learning approach identifies gene-regulating factor-mediated competing endogenous RNA networks in hormone-dependent cancers. J Cell Biochem 2022. [PMID: 35757968 DOI: 10.1002/jcb.30300] [Reference Citation Analysis]
13 Sudan S, Zhan X, Li J. A Novel Probiotic Bacillus subtilis Strain Confers Cytoprotection to Host Pig Intestinal Epithelial Cells during Enterotoxic Escherichia coli Infection. Microbiol Spectr 2022;:e0125721. [PMID: 35736372 DOI: 10.1128/spectrum.01257-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Sabnis RW. Indazole and Benzoisoxazole Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia. ACS Med Chem Lett 2022;13:763-4. [PMID: 35586439 DOI: 10.1021/acsmedchemlett.2c00150] [Reference Citation Analysis]
15 Guéguinou M, Ibrahim S, Bourgeais J, Robert A, Pathak T, Zhang X, Crottès D, Dupuy J, Ternant D, Monbet V, Guibon R, Flores-romero H, Lefèvre A, Lerondel S, Le Pape A, Dumas J, Frank PG, Girault A, Chautard R, Guéraud F, García-sáez AJ, Ouaissi M, Emond P, Sire O, Hérault O, Fromont-hankard G, Vandier C, Tougeron D, Trebak M, Raoul W, Lecomte T. Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04311-4] [Reference Citation Analysis]
16 So J, Lewis AC, Smith LK, Stanley K, Franich R, Yoannidis D, Pijpers L, Dominguez P, Hogg SJ, Vervoort SJ, Brown FC, Johnstone RW, McDonald G, Ulanet DB, Murtie J, Gruber E, Kats LM. Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia. EMBO Mol Med 2022;:e15203. [PMID: 35514210 DOI: 10.15252/emmm.202115203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lonati C, Dondossola D, Zizmare L, Battistin M, Wüst L, Vivona L, Carbonaro M, Zanella A, Gatti S, Schlegel A, Trautwein C. Quantitative Metabolomics of Tissue, Perfusate, and Bile from Rat Livers Subjected to Normothermic Machine Perfusion. Biomedicines 2022;10:538. [DOI: 10.3390/biomedicines10030538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Walter M, Herr P. Re-Discovery of Pyrimidine Salvage as Target in Cancer Therapy. Cells 2022;11:739. [PMID: 35203388 DOI: 10.3390/cells11040739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Sabnis RW. Heterocyclic Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML). ACS Med Chem Lett 2021;12:1641-2. [PMID: 34795852 DOI: 10.1021/acsmedchemlett.1c00532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zeng Z, Jiang X, Pan Z, Zhou R, Lin Z, Tang Y, Cui Y, Zhang E, Cao Z. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma. Aging (Albany NY) 2021;13:22802-29. [PMID: 34607313 DOI: 10.18632/aging.203574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 So J, Lewis AC, Smith LK, Stanley K, Pijpers L, Dominguez P, Hogg SJ, Vervoort SJ, Johnstone RW, Mcdonald G, Ulanet DB, Murtie J, Gruber E, Kats LM. Inhibition of pyrimidine biosynthesis targets protein translation in AML.. [DOI: 10.1101/2021.09.24.461627] [Reference Citation Analysis]